Osteoinductive alternatives and bone substitutes

Current Opinion in Orthopaedics

Volumn 9, Issue 6, 1998, Pages 31-37

  Uludag, Hasan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; HYDROXYAPATITE;

ARTICLE; AUTOGRAFT; BONE GRAFT; BONE MARROW CELL; BONE REGENERATION; BONE REMODELING; BONE TRANSPLANTATION; COLLAGEN METABOLISM; GENE TARGETING; HUMAN; PRIORITY JOURNAL; SPINE FUSION; STEM CELL;

EID: 0032448778     PISSN: 10419918     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001433-199812000-00006     Document Type: Article

References (68)

1. 1. Norman-Taylor FH, Villar RN: Bone allograft: a cause for concern. J Bone Joint Surg Br 1997, 79:178-80.
2. 2. Goulet JA, Senunas LE, DeSilva GL, Greenfield MLVH: Autogenous iliac crest bone graft: complications and functional assessment. Clin Orthop 1997, 339:76-81.
3. 3. Boyan BD, Nasatzky E, Keller TA, Schwartz Z: Bone graft substitutes. Curr Opin Orthop 1997, 9:86-92.
4. 4. Deijkers RLM, Bloem RM, Petit PLC, Brand R, Vehmeyer SB, Veen MR: Contamination of bone allografts: analysis of incidence and predisposing factors. J Bone Joint Surg Br 1997, 79:161-166.
5. 5. Urist MR: Bone morphogenetic protein: the molecularization of skeletal system development. J Bone Miner Res 1997, 12:343-346.
6. 6. Wozney JM, Rosen V: Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop 1998, 346:26-37.
7. 7. Reddi AH: Role of bone morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotech 1998, 16:247-252.
8. 8. Ripamonti U, Duneas N: Tissue morphogenesis and regeneration by bone morphogenetic proteins. Plast Reconst Surg 1998, 101:227-239.
9. 9. Stone CA: A molecular approach to bone regeneration. Br J Plast Surg 1997, 50:369-373.
10. 10. Lee MB: Bone morphogenetic proteins: background and implications for oral construction. A review. J Clin Peridontol 1997, 24:355-365.
11. 11. Singleton DG, Torres-Cabassa A: Regulatory issues relating to therapeutics for periodontal regeneration. Ann Periodontol 1997, 2:223-228.
12. 12. Hollinger JO, Schmitz JP: Macrophysiologic roles of a delivery system for vulnerary factors needed for bone regeneration. Ann N Y Acad Sci 1997, 831:427-437.
13. 13. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lily LC, Alder M, Nummikoski P: A feasibility study evaluation rhBMP-2/absorbable collagen sponge for maxillary sinus augmentation. Int J Periodont Rest Dent 1997, 17:11-25. One of the first studies to report on the clinical performance of an osteoinductive factor.
14. 14. Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, et al.: A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for alveolar ridge preservation of augmentation. Int J Periodont Rest Dent 1997, 17:11-25. One of the first studies to report on the clinical performance of an osteoinductive factor.
15. 15. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO: Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 1997, 79:1778-1790.
16. 16. Helm GA, Sheehan JM, Sheehan JP, Jane JA Jr, DiPierro CG, Simmons NE, et al.: Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumber spinal fusion. J Neurosurg 1997, 86:93-100.
17. 17. Kinoshita A, Oda S, Takahashi K, Yokota S, Ishikawa I: Periodontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodentitis in beagle dogs. J Periodontol 1997, 68:103-109.
18. 18. Ripamonti U, Reddi AH: Tissue engineering, morphogenesis and regeneration of periodontal tissues by bone morphogenetic proteins. Crit Rev Oral Biol Med 1997, 8:154-163.
19. 19. Sundhu HS, Kamin LEA, Toth JM, Kabo JM, Liu D, Delamarter RB, Dawson EG: Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine 1997, 22:1171-1180.
20. 20. Zellin G, Linde A: Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2. Scand J Plast Reconst Surg Hand Surg 1997, 31:97-104.
21. 21. Tsuruga E, Takita H, Itoh H, Wakisaka Y, Kuboki Y: Pore size of porous hydroxyapatite as the cell substratum controls BMP-induced osteogenesis. J Biochem 1997, 121:317-324.
22. 22. Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjo UM: Bone formation and reosseointegration in peri-implantatis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 1997, 12:604-610.
23. 23. Terheyden H, Jepsen S, Vogeler S, Tucker M, Rueger DC: Recombinant human osteogenic protein 1 in the rat mandibular augmentation model: differences in morphology of the newly formed bone are dependent on the type of carrier. Mund Kiefer Gesichtschirurgie 1997, 1:272-275.
24. 24. Cochran DL, Nummikoski PV, Jones AA, Makins SR, Turek, TJ, Buser D: Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2. Int J Oral Maxillofac Implants 1997, 12:739-748.
25. 25. Hanisch O, Tatakis DN, Rohrer MD, Wohrle PS, Wozney JM, Wikesjo UM: Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int J Oral Maxillofac Implants 1997, 12:785-792.
26. 26. Fischgrund JS, James SB, Chobat MC, Hankin R, Herkowitz HN, Wozney JM, Shirkhoda A: Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord 1997, 10:467-472.
27. 27. Boden SD, Martin GJ, Horton WC, Truss TL, Sandhu HS: Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 1998, 11:95-101.
28. 28. Kirker-Head CA, Gerhart TN, Armstrong R, Schelling SHJ, Carmel LA: Healing bone using recombinant human bone morphogenetic protein 2 and copolymer. Clin Orthop 1998, 349:205-217.
29. 29. Rodgers JB, Vasconez HC, Wells MD, DeLuca PP, Faugere M-C, Fink BF, Hamilton D: Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects. J Craniofac Surg 1998, 9:147-153.
30. 30. Wurtler KK, DeWeese TL, Sebald W, Reddi AH: Radiation induced impairment of bone healing can be overcome by recombinant human bone morphogenetic protein-2. J Craniofac Surg 1998, 9:131-137.
31. 31. Sellers RS, Peluso D, Morris EA: The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1997, 79:1452-1463.
32. 32. Kim HD, Smith JG, Valentini RF: Bone morphogenetic protein-2 coated porous poly-L-lactic acid scaffolds: release kinetics and induction of pluripotent C3H10T1/2 cells. Tissue Eng 1998, 4:35-51.
33. 33. Winn S, Uludag H, Hollinger J: Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Del Rev 1998, 31:303-318.
34. 34. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J: Pharmacokinetic characterization of rhBMP-2 implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 1998, in press.
35. 35. Uludag H, Friess W, Williams D, Timony G, D'Augusta D, Sargent C, Biron R, Wozney JM: rhBMP/collagen sponges as osteoinductive devices: effects of sponge characteristics and protein pl on in vivo rhBMP pharmacokinetics. Ann N Y Acad Sci 1998, in press.
36. 36. Webb DJ, Gonias SL: Chemical modification of alpha2-macroglobulin to generate derivatives that bind transforming growth factor-beta with increased affinity. FEBS Lett 1997, 410:249-253. This study describes the importance of binding proteins on the biological activity of a BMP-related protein (TGF-β). A similar mechanism may be operational for BMPs in vivo.
37. 37. Gavish H, Bab I, Tartakovsky A, Chorev M, Mansur N, Greenberg Z, et al.: Human alpha2-macroglobulin is an osteogenic growth factor-binding proteins. Biochemistry 1997, 36:14883-14888.
38. 38. Uludag H, D'Augusta D, Palmer R, Golden J, Li J, Wozney J: A correlation between osteoinductive activity and local retention of recombinant human bone morphogenetic proteins. Proceedings of the 24th Annual Meeting of the Society for Biomaterials (US), San Diego, CA. 1998:147.
39. 39. Laitinen M, Jortikka L, Halttunen T, Nevalainen J, Aho AJ, Marttinen A, Lindholm TS: Measurement of total and local bone morphogenetic protein concentration in bone tumours. Int Orthop 1997, 21:188-193.
40. 40. Erlacher L, McCartney J, Piek E, Dijke PT, Yanagishita M, Oppermann H, Luyten FP: Cartilage-derived morphogenetic proteins and osteogenic protein-1 regulate osteogenesis. J Bone Miner Res 1998, 13:383-392.
41. 41. Wells JA: Hormone mimicry. Science 1996, 273:449-450.
42. 42. Wolfman NM, Hattersley G, Cox K, Celeste AJ, Nelson R, Yamaji N, et al.: Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7 members of the TGF-beta gene family. J Clin Invest 1997, 100:321-330. This study points out the possibility of using osteoinductive and related proteins for reconstruction of musculoskeletal tissue other than bone.
43. 43. Howell TH, Fiorellini, Paquette DW, Offenbacher S, Giannodile WV, Lynch SE: A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-1 in patients with periodontal disease. J Periodontol 1997, 68:1186-1193.
44. 44. Nakamura K, Kawaguchi H, Aoyama I, Hanada K, Hiyama Y, Awa T, et al.: Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits. J Orthop Res 1997, 15:307-313.
45. 45. Guicheux J, Gauthier O, Aguado E, Pilet P, Couillaud S, Jegou D, et al.: Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: a rabbit study. J Bone Miner Res 1998, 13:739-748.
46. 46. Grills BL, Schuijers JA, Ward AR: Topical application of nerve growth factor improves fracture healing in rats. J Orthop Res 1997, 15:235-242.
47. 47. Cuevas P, de Vaz V, Cuevas B, Martin-Martinez J, Picon-Molina M, Fernandez-Pereira A, Gimenez-Gallego G: Osteopromotion for cranioplasty: an experimental study in rats using acidic fibroblast growth factor. Surg Neural 1997, 47:242-246.
48. 48. Ripamonti U, Duneas N, van Den Heever B, Bosch C, Crooks J: Recombinant transforming growth factor-β1 induces endochondral bone in the baboon and synergizes with recombinant osteogenic protein-1 (bone morphogenetic protein-7) to initiate rapid bone formation. J Bone Miner Res 1997, 12:1548-1595.
49. 49. Takita H, Tsuruga E, Ono J, Kuboki Y: Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. Eur J Oral Sci 1997, 105:588-592.
50. 50. Fang J, Zhu Y-Y, Smiley E, Benadio J, Rouleau JP, Goldstein SA, et al.: Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci U S A 1996, 93:5753-5758.
51. 51. Lieberman JR, Le LQ, Stevenson S, Gorum WJ, Attawia MA, Finerman GM, Witte ON, Laurencin CT: A gene therapy approach toward bone regeneration using degradable polymeric materials. Proceedings of the 23rd Annual Meeting of the Society for Biomaterials (US), New Orleans, LA. 1997:50.
52. 52. Day CS, Kasemkijwattana C, Monetrey J, Floyd SS Jr, Booth D, Moreland MS, et al.: Myoblast-mediated gene transfer to the joint. J Orthop Res 1997, 15:894-903.
53. 53. Caplan AI: Mesenchymal stem cells. J Orthop Res 1991, 9:641-650.
54. 54. Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF: Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 1997, 15:546-557.
55. 55. Kadiyala S, Young RG, Thiede MA, Bruder SP: Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997, 6:125-134.
56. 56. Joyner CJ, Bennett A, Triffitt JT: Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. Bone 1997, 21:1-6.
57. 57. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE: Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997, 21:225-235.
58. 58. Zohar R, McCulloch CAG, Sampath K, Sodek J: Flow cytometric analysis of recombinant human osteogenic protein-1 (BMP-7) responsive subpopulations from fetal rat calvarial based on intracellular osteopontin content. Matrix Biol 1998, 16:295-306.
59. 59. Puleo DA: Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. J Cell Physiol 1997, 173:93-101.
60. 60. Onyia JE, Clapp DW, Long H, Hock JM: Osteoprogenitor cells as targets for ex-vivo gene transfer. J Bone Miner Res 1998, 13:20-30.
61. 61. Feuerbach D, Loetscher E, Buerki K, Sampath TK, Feyen JHM: Establishment of conditionally immortilized stromal cell lines from a temperature sensitive T-Ag transgenic mouse. J Bone Miner Res 1997, 12:179-190.
62. 62. Hicok KC, Thomas T, Gori F, Rickard DJ, Spelsberg TC, Riggs BL: Development and characterization of conditionally immortilized osteoblast precurser cell lines from human bone marrow stroma. J Bone Miner Res 1998, 13:205-217.
63. 63. Houghton A, Oyajobi BO, Foster GA, Russell RGG, Stringer BMJ: Immortilization of human marrow stromal cells by retroviral transduction with a temperature sensitive oncogene: identification of bipotential precursor cells capable of directed differentiation to either an osteoblast or adipocyte phenotype. Bone 1998, 22:7-16.
64. 64. Winn SR, Randolph G, Uludag H, Wong SC, Hollinger JO: Establishing an immortilized human osteoprecurser cell line: OPC1. J Bone Miner Res 1998, in press.
65. 65. Kuznetsov AS, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG: Single colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997, 12:1335-1347.
66. 66. Krymanski G, Kalczak M, Wiktor-Jedrejczak W: The use of bone-marrow derived fibroblastoid cells and fresh bone marrow in the treatment of bone defects: an experimental study. Int J Oral Maxillofac Surg 1997, 26:55-60.
67. 7-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein. Matrix Biol 1997, 16:21-28. A novel method is presented to make nonadhesive biomaterials suitable for cell attachment. Such a method has the potential to improve the osseointegration of bone substitutes.
68. 68. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE: The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone sialoproteins. J Biomed Mater Res 1997, 37:9-19.